Navigation Links
Taiho Pharmaceutical ansöker om godkännande att tillverka och sälja det nya antitumörpreparatet TAS-102
Date:2/26/2013

ntemot placebo. Detta är en global fas-III studie som kommer att omfatta totalt 800 patienter från Japan, Nordamerika, Europa och Australien. Registreringen av patienter började i juni 2012. De patienter som deltar har icke resektabel, avancerad, återkommande kolorektal cancer som är refraktär mot standardcytostatika (fluoropyrimidin, irinotekan, oxaliplatin, bevacizumab samt, för patienter med tumörer som innehåller vildtyp av KRAS-genen, en anti-EGFR monoklonal antikropp). Studien kommer att jämföra patienter som slumpmässigt tilldelats TAS-102 eller placebo för att undersöka effektiviteten och säkerheten hos TAS-102. Det primära effektmåttet är total överlevnad. De huvudansvariga forskarna är Dr. Atsushi Otsu , direktör för det kliniska utvecklingscentrat på National Cancer Center Hospital East (Japan), Dr. Robert J. Mayer från Dana Farber Cancer Institute (USA), samt Dr. Eric Van Cutsem från universitetssjukhuset i Gasthuisberg (Belgium).

Om Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical, ett dotterbolag till Otsuka Holdings Co., Ltd. (http://www.otsuka.com/en/), är ett forskningsdrivet specialiserat läkemedelsföretag som fokuserar på de tre områdena onkologi, allergier och immunologi, samt urologi. Dess företagsfilosofi är formulerat som en utfästelse: "Vi strävar efter att förbättra människors hälsa och bidra till ett bättre samhälle." Särskilt inom onkologiområdet är Taiho Pharmaceutical känt som ett av de ledande företagen i Japan och runt om i världen när det gäller utveckling
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
2. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
3. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
4. Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
5. Taiho Pharmaceutical presenta una solicitud para fabricar y comercializar el nuevo agente antitumoral TAS-102
6. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
7. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
8. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
9. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
10. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015 Increase in R&D ... market in Germany through 2020 ... Research report, " Germany Bioinformatics Market Forecast & Opportunities, ... is projected to register a CAGR of over ... tremendous growth on account of rising government funding and ...
(Date:7/6/2015)... 29, 2015 Research and ... "Pharmaceutical Packaging Market in North America 2015-2019" ... market in North America to ... 2014-2019. International regulations regarding safe drug ... which in turn fuels adoption of sustainable packaging. Various ...
(Date:7/6/2015)... 6, 2015 Cardinal Health today announced the ... (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related ... was owned by Court Square Capital Partners. The $1.115 ... and new debt.  Headquartered in ... had revenues of approximately $450 million in 2014. There ...
Breaking Medicine Technology:Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3
... WOONSOCKET, R.I., Oct. 18, 2011 A recent ... up germs, they are not doing all they can to ... receiving an annual flu shot as recommended by the Centers ... http://photos.prnewswire.com/prnh/20100816/NE50800LOGO) The CDC recommends that anyone ages 6 ...
... With connectivity enabled by Unlimited Systems Interlink integration ... only helps cancer clinics easily meet many of the ... saves time and money by reducing duplicate data entry, ... claims payment and reduced denials. Clinics can ...
Cached Medicine Technology:CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 2CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 3CVS/pharmacy Survey Reveals Consumer Misconceptions Standing in the Way of Getting a Flu Shot 4Navigating Cancer and Unlimited Systems Partner to Provide Cancer Clinics With IT Interoperability to Attain HITECH Act Incentives 2
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student special (high ... of unlimited classes for just $65. Student ID is needed at registration. , Women's ... Lake Orion. , Women’s Excellence is the most comprehensive obstetric and ...
(Date:7/4/2015)... ... 2015 , ... Dating a real millionaire online can be more difficult. ... and strives to remove the worries from meeting partners. Recently, the site announced ... of 2015 and readers have responded with excitement. , “There's quite a few ...
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck ... sufferers have pain located in the neck. Another 19% suffer from head, migraine, or ... literature suggests that 45% of American workers must deal with neck pain. ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project ... technical sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), ... most highly respected and well established national certification organization for renewable energy professionals. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's ... creating a buzz of media attention. In an effort to spread the news, ... Hendricks. , "These days many people are feeling overwhelmed by stress and fatigue," ...
Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3
... Two methods that permit scientists to examine ... months release of Cold Spring Harbor Protocols . ... www.cshprotocols.org ), describe how to fluorescently tag cells in ... sophisticated imaging methods, permit scientists to visualize even subtle ...
... Splash with Las Vegas and Tucson Marathon Runners, ... ibuprofen,before an event to prevent inflammation and pain, but ... studies by researchers at,Appalachian State University and Vanderbilt University, ... that taking ibuprofen,before exercise may be unhealthy in the ...
... 3 As momentum continues to,build on the ... in Medicare, the Pharmaceutical Care Management Association,(PCMA) today ... J. Lyle,Bootman, Ph.D., Sc.D., Last year, Dr. ... recommended that all physicians begin using e-prescribing by,2010 ...
... Home Front Needs of Families with Deployed Service Members ... ... Alliance will present $15,000 to the Missouri National Guard -,Missouri Military Family Relief ... and their families., Don Brown, market vice president for the central market ...
... HUNTSVILLE, Ala., Dec. 3 Operon,Biotechnologies, Eurofins MWG ... Genomics network - announced today that they have ... new worldwide leader in the competitive,custom oligonucleotide market. ... of,the art high-throughput production facilities in all major ...
... and CEO retires; Mike Gallagher, President and ... MIAMI, Dec. 3 AvMed Health Plans ... announced plans to retire December 31,2007. As a ... parent company,SantaFe HealthCare, who already has overall leadership ...
Cached Medicine News:Health News:Cold Spring Harbor Protocols features innovative methods for embryology research 2Health News:Marathoners Share Tom Brady and LaDainian Tomlinson Pain Relief Affinity 2Health News:TriWest Contributes $15,000 to Missouri National Guard Fund 2Health News:MWG and Operon Are Joining Forces 2Health News:AvMed Announces Senior Leadership Changes 2
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
Medicine Products: